AAAAAA

   
Results: 1-14 |
Results: 14
SPASMODIC TORTICOLLIS - A MULTICENTER STU DY ON BEHAVIORAL-ASPECTS
Authors: SCHEIDT CE RAYKI O NICKEL T HEINEN F WISSEL J POEWE W BENECKE R ARNOLD G OERTEL W DENGLER R DEUSCHL G
Citation: Ce. Scheidt et al., SPASMODIC TORTICOLLIS - A MULTICENTER STU DY ON BEHAVIORAL-ASPECTS, PPmP. Psychotherapie, Psychosomatik, medizinische Psychologie, 48(1), 1998, pp. 1-12
ELECTRICAL-STIMULATION OF THE POSTEROVENTRAL PALLIDUM INFLUENCES INTERNALLY GUIDED SACCADES IN PARKINSONS-DISEASE
Authors: STRAUBE A DITTERICH J OERTEL W KUPSCH A
Citation: A. Straube et al., ELECTRICAL-STIMULATION OF THE POSTEROVENTRAL PALLIDUM INFLUENCES INTERNALLY GUIDED SACCADES IN PARKINSONS-DISEASE, Journal of neurology, 245(2), 1998, pp. 101-105
A COMBINATION OF STANDARD AND SUSTAINED-RELEASE L-DOPA BENSERAZIDE IMPROVES PERIODIC LIMB MOVEMENTS AND SUBJECTIVE SLEEP QUALITY IN THE RESTLESS LEGS SYNDROME/
Authors: COLLADOSEIDEL V KAZENWADEL J KOHNEN R WETTER TC SELZER R OERTEL W TRENKWALDER C
Citation: V. Colladoseidel et al., A COMBINATION OF STANDARD AND SUSTAINED-RELEASE L-DOPA BENSERAZIDE IMPROVES PERIODIC LIMB MOVEMENTS AND SUBJECTIVE SLEEP QUALITY IN THE RESTLESS LEGS SYNDROME/, Neurology, 50(4), 1998, pp. 5040-5040
WHAT IS THE OPTIMAL DOSE OF BOTULINUM TOXIN-A IN THE TREATMENT OF CERVICAL DYSTONIA - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY USING DYSPORT(R)
Authors: POEWE W DEUSCHL G NEBE A FEIFEL E WISSEL J BENECKE R KESSLER KR CEBALLOSBAUMANN AO OHLY A OERTEL W KUNIG G
Citation: W. Poewe et al., WHAT IS THE OPTIMAL DOSE OF BOTULINUM TOXIN-A IN THE TREATMENT OF CERVICAL DYSTONIA - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY USING DYSPORT(R), Journal of Neurology, Neurosurgery and Psychiatry, 64(1), 1998, pp. 13-17
DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE
Authors: LOEFFLER M DIEHL V PFREUNDSCHUH M RUHL U HASENCLEVER D NISTERSBACKES H SIEBER M TESCH H FRANKLIN J GEILEN W BARTELS H CARTONI C DOLKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HILLER E HINKELBEIN H HINTERBERGER W KIRCHNER H KOCH P KRUGER B KURTEN H KUTZNER K LOOS U MENDE W MULLER H OERTEL W PETSCH S PFAB R PFLUGER H ROHLOFF R SAUER R SCHALK K SCHICK HD SCHOPPE W SZEPESI S TEICHMANN J WORST P FISCHER R GEORGII A HUBNER K SCHWARZE EW
Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287
NEW SURGICAL THERAPIES IN PARKINSONS-DISE ASE - NEUROSTIMULATION AND TRANSPLANTATION
Authors: KUPSCH A OERTEL W
Citation: A. Kupsch et W. Oertel, NEW SURGICAL THERAPIES IN PARKINSONS-DISE ASE - NEUROSTIMULATION AND TRANSPLANTATION, Aktuelle Neurologie, 24(2), 1997, pp. 49-55
CATECHOL-O-METHYLTRANSFERASE INHIBITION WITH TOLCAPONE REDUCES THE WEARING OFF PHENOMENON AND LEVODOPA REQUIREMENTS IN FLUCTUATING PARKINSONIAN-PATIENTS
Authors: BAAS H BEISKE AG GHIKA J JACKSON M OERTEL WH POEWE W RANSMAYR G AUFF E VOLC D DUPONT E MIKKELSEN B WERMUTH L WOMMPETERSEN J BENECKE R EICHHOM T KOLBE H OERTEL W SCHIMRIGK K OLSSON JE PALHAGEN S BURGUNDER JM GHIKA A REGLI F STECK A MEDCALF P
Citation: H. Baas et al., CATECHOL-O-METHYLTRANSFERASE INHIBITION WITH TOLCAPONE REDUCES THE WEARING OFF PHENOMENON AND LEVODOPA REQUIREMENTS IN FLUCTUATING PARKINSONIAN-PATIENTS, Journal of Neurology, Neurosurgery and Psychiatry, 63(4), 1997, pp. 421-428
ACUTE MPTP TREATMENT PRODUCES NO CHANGES IN MITOCHONDRIAL COMPLEX ACTIVITIES AND INDEXES OF OXIDATIVE DAMAGE IN THE COMMON MARMOSET EX-VIVOONE WEEK AFTER EXPOSURE TO THE TOXIN
Authors: GERLACH M GOTZ M DIRR A KUPSCH A JANETZKY B OERTEL W SAUTTER J SCHWARZ J REICHMANN H RIEDERER P
Citation: M. Gerlach et al., ACUTE MPTP TREATMENT PRODUCES NO CHANGES IN MITOCHONDRIAL COMPLEX ACTIVITIES AND INDEXES OF OXIDATIVE DAMAGE IN THE COMMON MARMOSET EX-VIVOONE WEEK AFTER EXPOSURE TO THE TOXIN, Neurochemistry international, 28(1), 1996, pp. 41-49
DIFFERENTIATION OF ULVA-MUTABILIS (CHLOROPHYTA) GAMETANGIA AND GAMETERELEASE ARE CONTROLLED BY EXTRACELLULAR INHIBITORS
Authors: STRATMANN J PAPUTSOGLU G OERTEL W
Citation: J. Stratmann et al., DIFFERENTIATION OF ULVA-MUTABILIS (CHLOROPHYTA) GAMETANGIA AND GAMETERELEASE ARE CONTROLLED BY EXTRACELLULAR INHIBITORS, Journal of phycology, 32(6), 1996, pp. 1009-1021
FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE
Authors: DIEHL V LOEFFLER M PFREUNDSCHUH M RUEHL U HASENCLEVER D NISTERSBACKES H SIEBER M SMITH K TESCH H GEILEN W ADLER M BARTELS H BRANDENBURG U DIEZLER P DOELKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HECHT T HILLER E HINKELBEIN H LATHAN B KIRCHNER H KUEHN G KUERTEN H LOOS U MAKOSKI B OERTEL W PETSCH S PFAB R PFLUEGER H PLANKER M ROHLOFF R SACK H SAMANDARI S SAUER R SCHALK K SCHMITZ G SCHOPPE W SCHWIEDER G SZEPESI S TEICHMANN J WILHELMY W WORST P FISCHER R GEORGII A HUEBNER K SCHWARZE EW
Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910
NEUROTOXICITY INDUCED BY PRENATAL EXPOSURE TO MPTP ON THE MONOAMINERGIC AND PEPTIDERGIC SYSTEMS OF THE MARMOSET BRAIN
Authors: PEREZOTANO I LUQUIN MR OSET C HERRERO MT KUPSCH A OERTEL W OBESO JA DELRIO J
Citation: I. Perezotano et al., NEUROTOXICITY INDUCED BY PRENATAL EXPOSURE TO MPTP ON THE MONOAMINERGIC AND PEPTIDERGIC SYSTEMS OF THE MARMOSET BRAIN, Experimental neurology, 131(1), 1995, pp. 108-113
DISEASES OF THE BASAL GANGLIA - REVIEW OF THE PERIOD 1992-1993
Authors: OERTEL W
Citation: W. Oertel, DISEASES OF THE BASAL GANGLIA - REVIEW OF THE PERIOD 1992-1993, Aktuelle Neurologie, 21(4), 1994, pp. 141-148
STRIATAL D2-DOPAMINE RECEPTOR OCCUPANCY DURING TREATMENT WITH TYPICALAND ATYPICAL NEUROLEPTICS
Authors: SCHERER J TATSCH K SCHWARZ J OERTEL W KIRSCH MC ALBUS M
Citation: J. Scherer et al., STRIATAL D2-DOPAMINE RECEPTOR OCCUPANCY DURING TREATMENT WITH TYPICALAND ATYPICAL NEUROLEPTICS, Biological psychiatry, 36(9), 1994, pp. 627-629
PSYCHOSOCIAL-ASPECTS OF PARKINSONS-DISEASE
Authors: ELLGRING H SEILER S PERLETH B FRINGS W GASSER T OERTEL W
Citation: H. Ellgring et al., PSYCHOSOCIAL-ASPECTS OF PARKINSONS-DISEASE, Neurology, 43(12), 1993, pp. 41-44
Risultati: 1-14 |